Allied Market Research


Calming And Sleeping Market

Calming and Sleeping Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. They are used to treat insomnia, sleep apnea, and other sleep disorders.

The rise in hectic, stressful life, and reduced sleep time due to modern lifestyles such as digital communication, games, work, and social responsibilities drive the growth of the calming and sleeping market. The increasing trend of late night coffee and tea consumption leads to a disturbance in sleeping patterns that fuel the growth of the calming and sleep market. In addition, the rising prevalence of sleep disorders such as insomnia, sleep apnea, sleep walking, and bruxism among others is anticipated to propel the market growth.

However, dependence, adverse effects, misuse of calming and sleeping products, & stringent government regulations related to the safety and efficacy of calming & sleeping products hinder the market growth. Ongoing R&D activities related to calming and sleeping products are anticipated to present new opportunities for the market.

The market is segmented on the basis of product type, application, and geography. Based on product type, the market is categorized into medication, sleep laboratories, sleep apnea devices, and mattresses & pillows. By application, it is segmented into insomnia, sleep apnea, restless leg syndrome (RLS), bruxism, narcolepsy, and sleepwalking. The geographical breakdown of each of the aforesaid segments has been covered for North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global calming and sleeping market with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predicts the competitive outlook of the market.

Calming and Sleeping Market Report Highlights

Aspects Details
By Product Type
  • Medications
  • Prescriptions
  • Over-The-Counter (OTC)
  • Sleep Laboratories
  • Sleep Apnea Devices
  • Mattresses and Pillows
By Application
  • Insomnia
  • Sleep apnea
  • Restless Leg Syndrome (RLS)
  • Bruxism
  • Narcolepsy
  • Sleepwalking
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Rest of Asia-Pacific)
  • LAMEA  (Latin America, The Middle East, Africa)
Key Market Players

Roscoe Medical Inc., Acura Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., Eli Lilly and Company, Durect Corporation, AstraZeneca Plc., Collegium Pharmaceutical, Inc., Johnson & Johnson, Cara Therapeutics, Teva Pharmaceutical Industries Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Calming and Sleeping Market

Global Opportunity Analysis and Industry Forecast, 2023-2032